Healthstream (HSTM) Cash & Equivalents (2010 - 2026)

Healthstream (HSTM) has 17 years of Cash & Equivalents data on file, last reported at $48.7 million in Q1 2026.

• Quarterly Cash & Equivalents fell 36.98% year-over-year to $48.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $48.7 million (down 36.98% YoY) and the FY2025 annual result came in at $36.2 million, down 39.19% from the prior year.
• Cash & Equivalents advanced to $48.7 million in Q1 2026 per HSTM's latest filing, from $36.2 million in the prior quarter.
• Across five years, Cash & Equivalents topped out at $77.3 million in Q1 2025 and bottomed at $25.8 million in Q2 2023.
• The 5-year median for Cash & Equivalents is $48.3 million (2022), against an average of $48.1 million.
• The widest annual swing landed in 2024, when Cash & Equivalents soared 78.77%; it then tumbled 39.19% in 2025.
• Tracing HSTM's Cash & Equivalents over 5 years: stood at $46.0 million in 2022, then slipped by 12.36% to $40.3 million in 2023, then soared by 47.45% to $59.5 million in 2024, then plunged by 39.19% to $36.2 million in 2025, then jumped by 34.71% to $48.7 million in 2026.
• Per Business Quant, the three latest HSTM Cash & Equivalents figures stand at $48.7 million (Q1 2026), $36.2 million (Q4 2025), and $53.5 million (Q3 2025).

Peer Comparison